Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IX
Stefan Aebi(University of Bern), Aron Goldhirsch(European Institute of Oncology), Edda Simoncini(International Breast Cancer Study Group), Richard D. Gelber(Harvard University), Danielle Braun(Dana-Farber Cancer Institute), Jurij Lindtner(International Breast Cancer Study Group), Giulia Viale(Vita-Salute San Raffaele University), Meredith M. Regan(Harvard University), Diana Crivellari(Centro di Riferimento Oncologico), Manuela Rabaglio(University Hospital of Bern), Alan S. Coates(Breast Cancer Trials), Per Karlsson, Karen N. Price(International Breast Cancer Study Group), Ray Snyder(St Vincent's Hospital Melbourne), B.A. Gusterson, Zijie Sun(Stanford University), Monica Castiglione‐Gertsch
Cited by 55
Related Papers
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
|New England Journal of Medicine|1994|3.7k
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
|Annals of Oncology|2013|3.7k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k